Thiamine (vitamin B1) protects against glucose- and insulin-mediated proliferation of human infragenicular arterial smooth muscle cells

被引:23
作者
Avena, R
Arora, S
Carmody, BJ
Cosby, K
Sidawy, AN
机构
[1] George Washington Univ, Med Ctr, Vet Affairs Med Ctr, Dept Surg, Washington, DC 20037 USA
[2] Georgetown Univ, Med Ctr, Dept Surg, Vet Affairs Med Ctr, Washington, DC 20007 USA
关键词
D O I
10.1007/s100169910007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Accelerated proliferation of arterial smooth muscle cells (ASMC) plays an important role in the development of atherosclerosis, which preferentially affects the infragenicular vasculature in patients with diabetes mellitus. High insulin and glucose levels, which are present in patients with type II diabetes, have an additive effect in infragenicular ASMC proliferation in vitro. Thiamine is a coenzyme important in intracellular glucose metabolism. The objective of this study is to determine the effect of thiamine on human infragenicular ASMC proliferation induced by high glucose and insulin levels in vitro. Human infragenicular ASMC isolated from diabetic patients undergoing lower extremity amputation were used. Cells were cultured at 37 degrees C in 5% CO2. Cells were identified as ASMC by immunohistochemical analysis. Cells from passages 3-5 were exposed to glucose concentrations of 0.1 and 0.2% with and without insulin concentrations of 100 ng/mL and 1000 ng/mL, in the presence or absence of 200 CIM of thiamine. Standard hemocytometry and H-3-thymidine incorporation quantified cell proliferation after incubation for 6 days and 24 hr, respectively. The data suggest that thiamine inhibits human infragenicular ASMC proliferation induced by high glucose and insulin. Vitamin B1 intake may prove important in delaying the atherosclerotic complications of diabetes. DOI: 10.1007/s100169910007.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 17 条
[1]   Insulin like growth factor-1 receptors mediate infragenicular vascular smooth muscle cell proliferation in response to glucose and insulin not by insulin receptors [J].
Avena, R ;
Mitchell, ME ;
Carmody, B ;
Arora, S ;
Neville, RF ;
Sidawy, AN .
AMERICAN JOURNAL OF SURGERY, 1999, 178 (02) :156-161
[2]   The additive effects of glucose and insulin on the proliferation of infragenicular vascular smooth muscle cells [J].
Avena, R ;
Mitchell, ME ;
Neville, RE ;
Sidawy, AN .
JOURNAL OF VASCULAR SURGERY, 1998, 28 (06) :1033-1038
[3]   MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY [J].
GARCIA, MJ ;
MCNAMARA, PM ;
GORDON, T ;
KANNELL, WB .
DIABETES, 1974, 23 (02) :105-111
[4]  
Graier WF, 1995, EUR J PHARMACOL, V294, P221
[5]   Phenotypic characterization of human smooth muscle cells derived from atherosclerotic tibial and peroneal arteries [J].
Jones, BA ;
Aly, HM ;
Forsyth, EA ;
Sidawy, AN .
JOURNAL OF VASCULAR SURGERY, 1996, 24 (05) :883-891
[6]  
KENNEL WB, 1985, AM HEART J, V110, P1100
[7]  
LaSelva M, 1996, DIABETOLOGIA, V39, P1263
[8]   THE EPIDEMIOLOGY OF LOWER-EXTREMITY AMPUTATIONS IN DIABETIC INDIVIDUALS [J].
MOST, RS ;
SINNOCK, P .
DIABETES CARE, 1983, 6 (01) :87-91
[9]   Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase [J].
Nelson, PR ;
Yamamura, S ;
Mureebe, L ;
Itoh, H ;
Kent, KC .
JOURNAL OF VASCULAR SURGERY, 1998, 27 (01) :117-125
[10]   Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus - The glycemic threshold revisited [J].
Orchard, TJ ;
Forrest, KYZ ;
Ellis, D ;
Becker, DJ .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (16) :1851-1856